Research projects on cell and gene therapy for personalized medicine within EP PerMed
Notice title: Förderung von multidisziplinären transnationalen Forschungsvorhaben zum Thema: „Zell- und Gentherapie für die personalisierte Medizin“ (CGT4PM2027) innerhalb der Europäischen Partnerschaft für Personalisierte Medizin (EP PerMed)“
Funding for multidisciplinary transnational research consortia: Development and validation of innovative cell and gene therapies for personalized medicine. Objectives include the development/validation of cell and gene-based therapeutic approaches for clinical application, new diagnostic approaches for patient stratification or outcome prediction, improved characterization of cell and gene therapies (pharmacokinetics, biodistribution, pharmacodynamics, efficacy, safety, tolerability, effective dosing, and administration optimization), proof of principle (e.g., scientific publication, patent application), or the compilation of necessary in-vitro and in-vivo data for scientific advice to plan Phase I clinical trials. For advanced projects, further development towards GMP-compliant clinical manufacturing and the generation of quality and non-clinical data for an Investigational Medicinal Product Dossier are required. The measure is co-financed by the European Union and supports the goals of EP PerMed and Germany's High-Tech Agenda.
Never miss a tender again
We send you 3 current matches that fit your company.